Cargando…
Alzheimer’s disease treatment: The share of herbal medicines
One of the most frequent forms of dementia in neurological disorders is Alzheimer’s disease (AD). It is a chronic neurodegenerative disease characterized by impaired learning and memory. Pathological symptoms as extracellular amyloid-beta (Aβ) plaques and intracellular accumulation of neurofibrillar...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061323/ https://www.ncbi.nlm.nih.gov/pubmed/33953850 http://dx.doi.org/10.22038/IJBMS.2020.50536.11512 |
_version_ | 1783681542695944192 |
---|---|
author | Soheili, Masoud Karimian, Mohammad Hamidi, Gholamali Salami, Mahmoud |
author_facet | Soheili, Masoud Karimian, Mohammad Hamidi, Gholamali Salami, Mahmoud |
author_sort | Soheili, Masoud |
collection | PubMed |
description | One of the most frequent forms of dementia in neurological disorders is Alzheimer’s disease (AD). It is a chronic neurodegenerative disease characterized by impaired learning and memory. Pathological symptoms as extracellular amyloid-beta (Aβ) plaques and intracellular accumulation of neurofibrillary tangles occur in AD. Due to the aging of the population and increased prevalence of AD, discovery of new therapeutic agents with the highest effectiveness and fewer side effect seems to be necessary. Numerous synthetic medicines such as tacrine, donepezil, galantamine, rivastigmine, memantine, glutathione, ascorbic acid, ubiquinone, ibuprofen, and ladostigil are routinely used for reduction of the symptoms and prevention of disease progression. Nowadays, herbal medicines have attracted popular attention for numerous beneficial effects with little side effects. Lavandula angustifolia, Ginkgo biloba, Melissa officinalis, Crocus sativus, Ginseng, Salvia miltiorrhiza, and Magnolia officinalis have been widely used for relief of symptoms of some neurological disorders. This paper reviews the therapeutic effects of phytomedicines with prominent effects against various factors implicated in the emergence and progression of AD. |
format | Online Article Text |
id | pubmed-8061323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Mashhad University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-80613232021-05-04 Alzheimer’s disease treatment: The share of herbal medicines Soheili, Masoud Karimian, Mohammad Hamidi, Gholamali Salami, Mahmoud Iran J Basic Med Sci Review Article One of the most frequent forms of dementia in neurological disorders is Alzheimer’s disease (AD). It is a chronic neurodegenerative disease characterized by impaired learning and memory. Pathological symptoms as extracellular amyloid-beta (Aβ) plaques and intracellular accumulation of neurofibrillary tangles occur in AD. Due to the aging of the population and increased prevalence of AD, discovery of new therapeutic agents with the highest effectiveness and fewer side effect seems to be necessary. Numerous synthetic medicines such as tacrine, donepezil, galantamine, rivastigmine, memantine, glutathione, ascorbic acid, ubiquinone, ibuprofen, and ladostigil are routinely used for reduction of the symptoms and prevention of disease progression. Nowadays, herbal medicines have attracted popular attention for numerous beneficial effects with little side effects. Lavandula angustifolia, Ginkgo biloba, Melissa officinalis, Crocus sativus, Ginseng, Salvia miltiorrhiza, and Magnolia officinalis have been widely used for relief of symptoms of some neurological disorders. This paper reviews the therapeutic effects of phytomedicines with prominent effects against various factors implicated in the emergence and progression of AD. Mashhad University of Medical Sciences 2021-02 /pmc/articles/PMC8061323/ /pubmed/33953850 http://dx.doi.org/10.22038/IJBMS.2020.50536.11512 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Soheili, Masoud Karimian, Mohammad Hamidi, Gholamali Salami, Mahmoud Alzheimer’s disease treatment: The share of herbal medicines |
title | Alzheimer’s disease treatment: The share of herbal medicines |
title_full | Alzheimer’s disease treatment: The share of herbal medicines |
title_fullStr | Alzheimer’s disease treatment: The share of herbal medicines |
title_full_unstemmed | Alzheimer’s disease treatment: The share of herbal medicines |
title_short | Alzheimer’s disease treatment: The share of herbal medicines |
title_sort | alzheimer’s disease treatment: the share of herbal medicines |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061323/ https://www.ncbi.nlm.nih.gov/pubmed/33953850 http://dx.doi.org/10.22038/IJBMS.2020.50536.11512 |
work_keys_str_mv | AT soheilimasoud alzheimersdiseasetreatmenttheshareofherbalmedicines AT karimianmohammad alzheimersdiseasetreatmenttheshareofherbalmedicines AT hamidigholamali alzheimersdiseasetreatmenttheshareofherbalmedicines AT salamimahmoud alzheimersdiseasetreatmenttheshareofherbalmedicines |